Leaflet CLOPIDOGREL EIPICO 75mg film-coated tablets

Indicated for: prevention of atherothrombotic events

Route of administration: oral

Substance: clopidogrel (antiplatelet agent)

ATC: B01AC04 (Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin)

Precautions:
Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Clopidogrel is an antiplatelet medication used to prevent blood clots (thrombosis) in cardiovascular conditions. It is particularly indicated for patients at high risk of thrombotic events, such as myocardial infarction, ischemic stroke, or peripheral arterial disease. It is also used after procedures like coronary angioplasty or stent implantation to prevent stent occlusion.

Clopidogrel works by inhibiting platelet aggregation, blocking P2Y12 receptors on the surface of platelets. This mechanism prevents platelets from sticking together, reducing the risk of blood clot formation.

The medication is taken orally, usually once daily, and the dosage is determined by the doctor based on the condition being treated. It is important for patients to take clopidogrel as prescribed and not to stop the treatment without medical advice, as this may increase the risk of thrombotic events.

Common side effects include bleeding (e.g., gums, nose, or gastrointestinal tract), bruising, and gastrointestinal issues such as diarrhea or abdominal pain. Rarely, allergic reactions or a serious condition called thrombotic thrombocytopenic purpura (TTP) may occur.

Patients should inform their doctor about other medications they are taking, as clopidogrel can interact with certain treatments, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or anticoagulants, increasing the risk of bleeding.

General data about CLOPIDOGREL EIPICO 75mg

  • Substance: clopidogrel
  • Date of latest medicines list: 01-06-2026
  • Product code: W66626001
  • Concentration: 75mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 30
  • Product type: Generic medicine
  • Price: 41.94 RON
  • Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

  • Manufacturer: FELSIN FARM SRL - ROMANIA
  • Holder: E.I.P.I.CO MED S.R.L. - ROMANIA
  • Number: 12506/2019/01
  • Shelf life: 3 years

Pharmaceutical forms available for clopidogrel

Concentrations available for clopidogrel

  • 300mg
  • 75mg

Combinations with other substances

Compensation lists for CLOPIDOGREL EIPICO 75mg Eipico

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

41.94 RON

20.97 RON

20.97 RON

G3 (C1) - Patients with percutaneous interventional procedures

Price

Copayment

Patient

41.94 RON

24.85 RON

17.09 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

41.94 RON

24.85 RON

17.09 RON